11 – 20 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromes
(
- Contribution to journal › Article
-
Mark
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group
(
- Contribution to journal › Article
-
Mark
The International Consensus Classification of acute myeloid leukemia
(
- Contribution to journal › Scientific review
-
Mark
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
(
- Contribution to journal › Article
-
Mark
Multiparameter flow cytometry in the evaluation of myelodysplasia : Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow-Self Organizing Maps algorithm
(
- Contribution to journal › Article
-
Mark
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
(
- Contribution to journal › Scientific review
-
Mark
Mixed Phenotype/Lineage Leukemia : Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets
(
- Contribution to journal › Article